au.\*:("National cancer inst")
Results 1 to 25 of 86
Selection :
Methods and strategies in lung cancer controlCASTONGUAY, A.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2641s-2651s, issn 0008-5472Conference Paper
Laboratory of tumor cell biology. Annual meetingAIDS research and human retroviruses. 1994, Vol 10, pp S1-S170, issn 0889-2229, SUP3Conference Proceedings
Investigational strategies for detection and intervention in early lung cancerCancer research (Baltimore). 1992, Vol 52, Num 9, issn 0008-5472Conference Proceedings
Future studies in localized prostate cancer. That should we think ? What can we do ?LANGE, P. H.The Journal of urology. 1994, Vol 152, Num 5, pp 1932-1938, issn 0022-5347, 2Conference Paper
Problems and perspectives on the use of decision-analysis models for prostate cancerSIMPSON, K. N.The Journal of urology. 1994, Vol 152, Num 5, pp 1888-1893, issn 0022-5347, 2Conference Paper
Prostate cancer, screening and the generalist physicianROBERTS, R. G.The Journal of urology. 1994, Vol 152, Num 5, pp 1693-1694, issn 0022-5347, 2Conference Paper
Public health perspective : the health policy implications of screening for prostate cancerWOOLF, S. H.The Journal of urology. 1994, Vol 152, Num 5, pp 1685-1688, issn 0022-5347, 2Conference Paper
The role of watchful waiting in the management of localized prostate cancerCHODAK, G. W.The Journal of urology. 1994, Vol 152, Num 5, pp 1766-1768, issn 0022-5347, 2Conference Paper
Impact of radical prostatectomy in the management of clinically localized diseasePAULSON, D. F.The Journal of urology. 1994, Vol 152, Num 5, pp 1826-1830, issn 0022-5347, 2Conference Paper
Expectant management of early stage prostatic cancer : swedish experienceJOHANSSON, J.-E.The Journal of urology. 1994, Vol 152, Num 5, pp 1753-1756, issn 0022-5347, 2Conference Paper
Measuring health related quality of life in men with prostate cancerLITWIN, M. S.The Journal of urology. 1994, Vol 152, Num 5, pp 1882-1887, issn 0022-5347, 2Conference Paper
Prostate cancer : a patient's perspectiveHOWE, R. J.The Journal of urology. 1994, Vol 152, Num 5, pp 1700-1703, issn 0022-5347, 2Conference Paper
Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapyZAGARS, G. K.The Journal of urology. 1994, Vol 152, Num 5, pp 1786-1791, issn 0022-5347, 2Conference Paper
Nitrosamine-induced lung carcinogenesis and Ca2+/calmodulin antagonistsSCHÜLLER, H. M.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2723s-2726s, issn 0008-5472Conference Paper
The clinical evaluation of cancer chemoprevention agents : defining fand contrasting phase I, II, and III objectivesGOODMAN, G. E.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2752s-2757s, issn 0008-5472Conference Paper
Natural hisory of changes in prostate specific antigen in early stage prostate cancerPEARSON, J. D; CARTER, H. B.The Journal of urology. 1994, Vol 152, Num 5, pp 1743-1748, issn 0022-5347, 2Conference Paper
The use of prostate specific antigen for prostate cancer screening : a managed care perspectiveHANDLEY, M. R; STUART, M. E.The Journal of urology. 1994, Vol 152, Num 5, pp 1689-1692, issn 0022-5347, 2Conference Paper
Amplification and expression of the bcl-1 gene in human solid tumor cell linesFAUST, J. B; MEEKER, T. C.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2460-2463, issn 0008-5472Conference Paper
Clinical significance of ras oncogene activation in human lung cancerRODENHUIS, S; SLEBOS, R. J. C.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2665s-2669s, issn 0008-5472Conference Paper
Phosphatase inhibitors modulate the growth-regulatory effects of human tumor necrosis factor on tumor and normal cellsTOTPAL, K; AGARWA, S; AGGARWAL, B. B et al.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2557-2562, issn 0008-5472Conference Paper
Tumor cell kinetics following antineoplastic ether phospholipid treatmentPRINCIPE, P; SIDOTI, C; BRAQUET, P et al.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2509-2515, issn 0008-5472Conference Paper
Detection and treatment of prostate cancer : perspective of the urologistOLSSON, C. A; GOLUBOFF, E. T.The Journal of urology. 1994, Vol 152, Num 5, pp 1695-1699, issn 0022-5347, 2Conference Paper
Expectant management of clinically localized prostatic cancerWARNER, J; WHITMORE, W. F.The Journal of urology. 1994, Vol 152, Num 5, pp 1761-1765, issn 0022-5347, 2Conference Paper
Application of molecular genetics to the early diagnosis and screeting of lung cancerBIRRER, M. J; BROWN, P. H.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2658s-2664s, issn 0008-5472Conference Paper
Growth of small cell lung cancer cells : stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivoSETHI, T; LANGDON, S; SMYTH, J et al.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2737s-2742s, issn 0008-5472Conference Paper